Login to Your Account

Clinic Roundup

Wednesday, May 9, 2012
• Advaxis Inc., of Princeton, N.J., said two patients have been enrolled into a Phase I/II study sponsored by Cancer Research UK to test immunotherapy candidate ADXS-HPV for the treatment of human papillomavirus (HPV)-positive head and neck cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription